Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


21.03.23 / Tradegate WKN: A2ALQV / Name: Reata Pharms / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Reata Pharmaceuticals Inc Stock

A loss of -1.810% shows a downward development for Reata Pharmaceuticals Inc.
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Reata Pharmaceuticals Inc is rather balanced.
This results in a negative potential of -20.958% based on a current price of €83.50 and a target price of €66.00 for the stock.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Reata Pharmaceuticals Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Reata Pharmaceuticals Inc in the next few years

W********* I********* f** t** n*** y****
C******** o* t** e**********
M***** P*******
G***** c******* t* c**********
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Reata Pharmaceuticals Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Reata Pharmaceuticals Inc -1.810% 2.454% 114.103% 147.041% 142.733% - -
Immunic Inc. -5.100% -19.243% -26.677% -86.751% 4.916% -71.059% -
OncoCyte Corp -8.960% -24.667% -41.451% -82.063% -28.481% -90.661% -
Ocuphire Pharma Inc. -0.840% -7.232% 2.175% -6.844% 11.838% - -